AEMD — Aethlon Medical Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Aethlon Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.4 | -12 | -12.2 | -13.4 | -7.15 |
| Depreciation | |||||
| Non-Cash Items | 0.781 | 1.22 | 1.24 | 5.31 | 0.573 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.251 | 0.065 | 0.479 | 0.094 | -0.743 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -9.77 | -10.5 | -10.1 | -7.65 | -7 |
| Capital Expenditures | -0.349 | -0.943 | -0.251 | 0 | -0.004 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.349 | -0.943 | -0.251 | 0 | -0.004 |
| Financing Cash Flow Items | — | — | — | -0.165 | -1.22 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 17.4 | 8.91 | 1.29 | 7.73 | 6.52 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.25 | -2.54 | -9.09 | 0.07 | -0.474 |